AAI Read More Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug CollaborationJune 28, 2026 Alex Zhavoronkov, PhD, CEO of Insilico Medicine, inside the company’s robotics lab in Suzhou, China.[Insilico Medicine] Insilico Medicine…